Delivery Order SPE2DB20D2001-SPE2DB25FPNUJ
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,936.96 delivery order on July 23, 2025, for XYOSTED 75 mg/0.5 mL auto-injector units (0.5 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 24, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,062.43 to AmerisourceBergen Drug Corp for the supply of XYOSTED 50 mg/0.5 ml auto-injector units. The contract is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, awarded on August 21, 2025, with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $3,302.77 delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector units on April 25, 2025, with completion targeted for April 28, 2025. This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and represents a continuation of AmerisourceBergen's pharmaceutical supply role within the federal medical procurement system. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injector pre-filled syringes valued at $1,716.22. This is a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and represents a non-competitive set-aside award. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued...
- The Defense Logistics Agency awarded a $1,358.05 delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector units. This non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of August 28, 2025, and was awarded on August 27, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a $1,253.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector units. The contract, issued on September 19, 2025, with completion targeted for September 22, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). This IDC, valued at $999.999 billion through December 2026, serves as a comprehensive global pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector supplies, valued at $1,006.78 under a firm fixed-price arrangement. The award, issued on June 30, 2025, with an ultimate completion date of July 1, 2025, represents a non-competitive delivery order. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,403.64 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector vials on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product, reflecting the company's role in...
- The Defense Logistics Agency awarded a delivery order valued at $1,191.17 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector units on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,464.31 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies. This competitively awarded, firm fixed-price contract was issued on June 4, 2025, with an ultimate completion date of June 5, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. No set-aside designation was applied to this award, indicating open competition among qualified...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNUJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,597.81 on September 23, 2025, for XYOSTED 50 MG/0.5 ML auto-injector supplies (0.5 ML). The contract is structured as a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded procurement. Performance will occur at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. This award is a child contract issued under a larger vehicle, leveraging the company's existing framework agreement with the Defense Logistics Agency. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. XYOSTED is a testosterone replacement therapy auto-injector used in military medical supply chains, and this order represents a routine fulfillment of federal pharmaceutical procurement needs through AmerisourceBergen's established status as a critical vendor for federal medical distribution.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/23/25 |